Awareness of hepatitis C infection among women with and at risk for HIV
- PMID: 17924170
- PMCID: PMC2219830
- DOI: 10.1007/s11606-007-0395-x
Awareness of hepatitis C infection among women with and at risk for HIV
Abstract
Background: Treatment guidelines recommend all HIV/HCV-co-infected persons be considered for hepatitis C virus (HCV) treatment, yet obstacles to testing and accessing treatment for HCV continue for women.
Objective: To assess awareness of HCV, and describe diagnostic referrals and HCV treatment among women in the Women's Interagency HIV Study (WIHS).
Design: Prospective epidemiologic cohort.
Participants: Of 3,768 HIV-infected and uninfected women in WIHS, 1,166 (31%) were HCV antibody positive.
Measurements and main results: Awareness of HCV infection and probability of referrals for diagnostic evaluations and treatment using logistic regression. Follow-up HCV information was available for 681 (390 died, 15 withdrew, 80 missed visit) in 2004. Of these 681, 522 (76.7%) reported knowing their HCV diagnosis. Of these, 247 of 522 (47.3%) stated their providers recommended a liver biopsy, whereas 139 of 247 or 56.3% reported having a liver biopsy. A total of 170 of 522 (32.6%) reported being offered treatment and 74.1% (n = 126 of 170) reported receiving HCV treatment. In multivariate regression analyses, African-American race, Hispanic/Latina ethnicity, poverty, and current crack/cocaine/heroin use were negatively associated with treatment referrals, whereas elevated alanine aminotransferase (ALT) was associated with increased likelihood of referral and increased likelihood of treatment.
Conclusion: One quarter of women with HCV in this cohort were not aware of their diagnosis. Among those aware of their HCV, 1 in 4 received liver biopsy and treatment for HCV. Both provider and patient education interventions regarding HCV testing and HCV treatment options and guidelines are needed to enhance HCV awareness and participation in HCV evaluation and treatment.
Similar articles
-
Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.Dig Dis Sci. 2013 May;58(5):1341-8. doi: 10.1007/s10620-012-2486-8. Epub 2012 Nov 24. Dig Dis Sci. 2013. PMID: 23179159 Free PMC article.
-
Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.HIV Med. 2005 May;6(3):206-15. doi: 10.1111/j.1468-1293.2005.00291.x. HIV Med. 2005. PMID: 15876288
-
Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.Hepatology. 2012 Nov;56(5):1699-705. doi: 10.1002/hep.25859. Epub 2012 Aug 27. Hepatology. 2012. PMID: 22618868 Free PMC article.
-
Hepatitis C in African Americans.Am J Gastroenterol. 2014 Oct;109(10):1576-84; quiz 1575, 1585. doi: 10.1038/ajg.2014.243. Epub 2014 Sep 2. Am J Gastroenterol. 2014. PMID: 25178700 Review.
-
The Changing Science of HIV Epidemiology in the United States.Am J Epidemiol. 2019 Dec 31;188(12):2061-2068. doi: 10.1093/aje/kwz211. Am J Epidemiol. 2019. PMID: 31595945 Free PMC article. Review.
Cited by
-
Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.Am J Kidney Dis. 2009 Jul;54(1):43-50. doi: 10.1053/j.ajkd.2009.02.009. Epub 2009 Apr 25. Am J Kidney Dis. 2009. PMID: 19394735 Free PMC article.
-
"Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania.Malar J. 2014 Dec 13;13:491. doi: 10.1186/1475-2875-13-491. Malar J. 2014. PMID: 25495956 Free PMC article.
-
Prevalence and patient awareness of medical comorbidities in an urban AIDS clinic.AIDS Patient Care STDS. 2010 Jan;24(1):39-48. doi: 10.1089/apc.2009.0152. AIDS Patient Care STDS. 2010. PMID: 20095901 Free PMC article.
-
Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City.J Community Health. 2014 Jun;39(3):487-93. doi: 10.1007/s10900-013-9782-x. J Community Health. 2014. PMID: 24173529 Free PMC article.
-
Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure.Med Decis Making. 2014 Aug;34(6):800-8. doi: 10.1177/0272989X13507340. Epub 2013 Oct 8. Med Decis Making. 2014. PMID: 24106234 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16702586', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16702586/'}]}
- Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–14. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00004836-200609000-00014', 'is_inner': False, 'url': 'https://doi.org/10.1097/00004836-200609000-00014'}, {'type': 'PubMed', 'value': '16940888', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16940888/'}]}
- Bini EJ, Currie SL, Shen H, et al. National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gastroenterol. 2006;40:732–9. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/01.qco.0000200294.22661.e0', 'is_inner': False, 'url': 'https://doi.org/10.1097/01.qco.0000200294.22661.e0'}, {'type': 'PubMed', 'value': '16374211', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16374211/'}]}
- Rockstroh JK. Management of hepatitis C/HIV coinfection. Curr Opin Infect Dis. 2006;19:8–13. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/01.aids.0000192065.09281.01', 'is_inner': False, 'url': 'https://doi.org/10.1097/01.aids.0000192065.09281.01'}, {'type': 'PubMed', 'value': '16251809', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16251809/'}]}
- Backus LI, Boothroyd D, Deyton LR. HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. AIDS. 2005;19(Suppl 3):13–9. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1111/j.1525-1497.2004.30613.x', 'is_inner': False, 'url': 'https://doi.org/10.1111/j.1525-1497.2004.30613.x'}, {'type': 'PMC', 'value': 'PMC1492202', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1492202/'}, {'type': 'PubMed', 'value': '15061745', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15061745/'}]}
- Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco’s HIV-infected urban poor. J Gen Intern Med. 2004;19:357–65. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR000079/RR/NCRR NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- MO1-RR00083/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- MO1-RR00079/RR/NCRR NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- M01 RR000083/RR/NCRR NIH HHS/United States
- MO1-RRR00071/PHS HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical